|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 3.32B 2.91B 2.69B 2.49B 4.71B 318B 4.8B 32.33B 12.56B 156B 12.47B 12.2B 540B | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3.05B 2.82B 2.6B 4.93B 333B 5.03B 33.85B 13.15B 163B 13.06B 12.77B 566B | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/09/25 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 29/07/25 | Amedisys: Q2 Earnings Snapshot | AQ |
| 29/07/25 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 29/07/25 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 23/04/25 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 1 year | 96.72 |  | 101.02 |
| 3 years | 82.15 | | 101.02 |
| 5 years | 69.36 | | 271.32 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 05/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 31/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/08/25 | Issuer sale | Compliance Officer | 40,579 | 0.1239% | ||
| 13/08/25 | Issuer sale | Director | 23,992 | 0.0732% | ||
| 13/08/25 | Issuer sale | Controller/Auditor | 11,539 | 0.0352% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.24B 1.96B 1.81B 1.67B 3.17B 214B 3.24B 21.77B 8.46B 105B 8.4B 8.21B 364B | 2.35B 2.06B 1.9B 1.76B 3.33B 225B 3.4B 22.86B 8.88B 110B 8.82B 8.63B 382B |
| Net income | -9.75M -8.55M -7.89M -7.29M -13.82M -933M -14.1M -94.88M -36.87M -457M -36.6M -35.8M -1.59B | 43.23M 37.92M 35.01M 32.35M 61.31M 4.14B 62.54M 421M 164M 2.03B 162M 159M 7.03B |
| Net Debt | 361M 316M 292M 270M 512M 34.54B 522M 3.51B 1.36B 16.9B 1.35B 1.33B 58.68B | 156M 137M 126M 117M 221M 14.94B 226M 1.52B 590M 7.31B 586M 573M 25.38B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
